Author: admin

MONTREAL, Jan. 17, 2025 /CNW/ – Otsuka Pharmaceutical Canada Inc. (Otsuka) and Lundbeck Canada Inc. (Lundbeck) announce that Health Canada has issued a Notice of Compliance for ABILIFY ASIMTUFII® (aripiprazole prolonged release injectable suspension) for intramuscular use, a once-every-two-mo

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: